Temporal alterations of endothelial-vasodilator functions in lung injury induced by monocrotaline.

[1]  T. Ishizaki,et al.  Rapid and simple method for the simultaneous determination of 3,4-dihydroxyphenylacetic acid, 5-hydroxyindole-3-acetic acid and 4-hydroxy-3-methoxyphenylacetic acid in human plasma by high-performance liquid chromatography with electrochemical detection , 1998 .

[2]  T. McMahon,et al.  Analysis of responses to serotonin in the pulmonary vascular bed of the cat. , 1993, Journal of applied physiology.

[3]  J. Wagner,et al.  Comparison of response of bovine and porcine pulmonary arterial endothelial cells to monocrotaline pyrrole. , 1991, The American journal of physiology.

[4]  R. Mathew,et al.  O2 and rat pulmonary artery tone: effects of endothelium, Ca2+, cyanide, and monocrotaline. , 1991, Journal of applied physiology.

[5]  I. Ehrhart,et al.  Modulation of vascular reactivity to serotonin in the dog lung. , 1991, Journal of applied physiology.

[6]  A. Herman,et al.  Influence of vasoconstriction, temperature, and flow on the kinetics of serotonin uptake in rabbit lungs. , 1991, Journal of applied physiology.

[7]  J. Reindel,et al.  The effects of monocrotaline pyrrole on cultured bovine pulmonary artery endothelial and smooth muscle cells. , 1991, The American journal of pathology.

[8]  I. Ehrhart,et al.  Prostacyclin production with serotonin, increased flow, or elevated venous pressure in dog lung. , 1990, Journal of applied physiology.

[9]  S. O'Donnell,et al.  Endothelin and 5-hydroxytryptamine on rat pulmonary artery in pulmonary hypertension. , 1990, European journal of pharmacology.

[10]  S. Peroutka,et al.  5‐Hydroxytryptamine receptor “families” , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  A. Molteni,et al.  Monocrotaline-induced cardiopulmonary injury in rats. Modification by the neutrophil elastase inhibitor SC39026. , 1989, Biochemical pharmacology.

[12]  M. Rabinovitch,et al.  Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension. , 1988, The American journal of physiology.

[13]  I. Ehrhart,et al.  Vascular reactivity and permeability to serotonin in cyclooxygenase-inhibited dog lung. , 1988, American Journal of Physiology.

[14]  U. Ungerstedt,et al.  HPLC-EC analysis of catechols and indoles in rat brain dialysates. , 1987, Life sciences.

[15]  M. Gillespie,et al.  Altered pulmonary vascular smooth muscle responsiveness in monocrotaline-induced pulmonary hypertension. , 1986, Journal of Pharmacology and Experimental Therapeutics.

[16]  S. Tannenbaum,et al.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.

[17]  R. Roth,et al.  Pneumotoxicity and thrombocytopenia after single injection of monocrotaline. , 1982, The American journal of physiology.

[18]  G. Vawter,et al.  Early pulmonary vascular changes in congenital heart disease studied in biopsy tissue. , 1980, Human pathology.

[19]  H. B. Stoner,et al.  Pulmonary oedema in rats given monocrotaline pyrrole , 1972, The Journal of pathology.

[20]  A. Mattocks.  Toxicity of Pyrrolizidine Alkaloids , 1968, Nature.

[21]  Fulton Rm,et al.  VENTRICULAR WEIGHT IN CARDIAC HYPERTROPHY , 1952 .

[22]  K. Suzuki,et al.  Endothelial modulation of pH-dependent pressor response in isolated perfused rabbit lungs. , 1996, The American journal of physiology.

[23]  E. Mylecharane.  Mechanisms involved in serotonin-induced vasodilatation. , 1990, Blood vessels.

[24]  P. Ganey,et al.  6-keto prostaglandin F1 alpha and thromboxane B2 in isolated, buffer-perfused lungs from monocrotaline pyrrole-treated rats. , 1987, Experimental lung research.

[25]  R. Roth,et al.  Increased vascular responsiveness in lungs of rats with pulmonary hypertension induced by monocrotaline pyrrole. , 1985, The American review of respiratory disease.